CVS Group (CVSG) 주식 개요
CVS Group plc는 자회사와 함께 영국과 호주에서 수의학, 온라인 약국, 소매업에 종사하고 있습니다. 자세히 보기
CVSG Community Fair Values
Create NarrativeSee what 21 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
CVS Group plc 경쟁사
가격 이력 및 성과
| 과거 주가 | |
|---|---|
| 현재 주가 | UK£12.96 |
| 52주 최고가 | UK£16.48 |
| 52주 최저가 | UK£10.62 |
| 베타 | 1.07 |
| 1개월 변동 | 8.36% |
| 3개월 변동 | 2.13% |
| 1년 변동 | 0.31% |
| 3년 변동 | -37.51% |
| 5년 변동 | -47.10% |
| IPO 이후 변동 | 467.18% |
최근 뉴스 및 업데이트
내러티브 업데이트 • Jun 24
CVSG: Share Buyback Momentum Will Support Future Upside Potential
Analysts have kept their fair value estimate for CVS Group steady at £16.40, with small adjustments to assumptions such as the discount rate and future P/E leading to only a marginal change in the overall price target narrative. What’s in the News for CVS Group CVS Group commenced a share repurchase program on May 26, 2026, committing up to £50 million to buy back its shares.내러티브 업데이트 • Jun 06
CVSG: Activist Buyback Push And Index Inclusion Will Support Future Upside
Analysts have kept their £16.40 fair value estimate for CVS Group broadly unchanged, with a slightly higher discount rate and modest tweaks to revenue growth, profit margin and future P/E assumptions helping to frame a neutral stance following recent Street research. What's in the News Converium Capital Inc.
내러티브 업데이트 • May 22
CVSG: Neutral Coverage And Buyback Pressure Will Shape Future Earnings Profile
Analysts have trimmed their fair value estimate for CVS Group from £14.20 to £13.40, citing a slightly higher discount rate, updated assumptions for revenue growth and profit margins, and a modestly lower future P/E multiple following recent neutral Street research coverage. Analyst Commentary Recent Street research has taken a more cautious stance on CVS Group, with neutral positioning reflecting a balance between the company’s potential and a set of clear execution and valuation questions.내러티브 업데이트 • May 01
CVSG: Neutral Initiation And Stable Assumptions Will Support Higher Future Price Objective
Analysts have kept their fair value estimate for CVS Group steady at £16.40, with only small tweaks to revenue growth and profit margin assumptions. This reflects a neutral stance following recent Street research initiation.Recent updates
내러티브 업데이트 • Jun 24
CVSG: Share Buyback Momentum Will Support Future Upside Potential
Analysts have kept their fair value estimate for CVS Group steady at £16.40, with small adjustments to assumptions such as the discount rate and future P/E leading to only a marginal change in the overall price target narrative. What’s in the News for CVS Group CVS Group commenced a share repurchase program on May 26, 2026, committing up to £50 million to buy back its shares.내러티브 업데이트 • Jun 06
CVSG: Activist Buyback Push And Index Inclusion Will Support Future Upside
Analysts have kept their £16.40 fair value estimate for CVS Group broadly unchanged, with a slightly higher discount rate and modest tweaks to revenue growth, profit margin and future P/E assumptions helping to frame a neutral stance following recent Street research. What's in the News Converium Capital Inc.내러티브 업데이트 • May 22
CVSG: Neutral Coverage And Buyback Pressure Will Shape Future Earnings Profile
Analysts have trimmed their fair value estimate for CVS Group from £14.20 to £13.40, citing a slightly higher discount rate, updated assumptions for revenue growth and profit margins, and a modestly lower future P/E multiple following recent neutral Street research coverage. Analyst Commentary Recent Street research has taken a more cautious stance on CVS Group, with neutral positioning reflecting a balance between the company’s potential and a set of clear execution and valuation questions.내러티브 업데이트 • May 01
CVSG: Neutral Initiation And Stable Assumptions Will Support Higher Future Price Objective
Analysts have kept their fair value estimate for CVS Group steady at £16.40, with only small tweaks to revenue growth and profit margin assumptions. This reflects a neutral stance following recent Street research initiation.내러티브 업데이트 • Apr 16
CVSG: Neutral Coverage And Steady Fundamentals Will Support Higher Future Price Objective
Analysts have maintained their fair value estimate for CVS Group at £16.40. This reflects a neutral recalibration of expectations that aligns with recent Street research highlighting a balanced risk and reward profile following the new coverage initiation.내러티브 업데이트 • Apr 02
CVSG: Neutral Coverage And Buybacks Will Support Higher Future Price Objective
Analysts have trimmed their fair value estimate for CVS Group from about £16.73 to roughly £16.40. This reflects slightly softer revenue growth assumptions, a modestly higher profit margin outlook and a small adjustment to the future P/E multiple following recent neutral coverage initiation.내러티브 업데이트 • Mar 19
CVSG: Completed Buyback And Margin Outlook Will Support A Stronger Future Earnings Profile
Analysts have kept their fair value estimate for CVS Group steady at £14.20. This reflects slightly lower assumed revenue growth, balanced by a modestly higher profit margin outlook and a small reduction in the future P/E multiple used in their models.내러티브 업데이트 • Mar 05
CVSG: Share Repurchase Completion Will Support Higher Future Price Objective
Analysts have inched their price target for CVS Group higher to £16.73 from £16.62, reflecting updated assumptions for fair value, discount rate, revenue growth and profit margins. What's in the News CVS Group completed a share buyback tranche, repurchasing 1,584,690 shares for £20 million, equal to 2.21% of its share capital, under the program announced on October 24, 2025 (Key Developments).내러티브 업데이트 • Feb 18
CVSG: Completed Buyback And Stable Assumptions Will Shape Balanced Near Term Outlook
Analysts have made only a marginal tweak to their fair value outlook for CVS Group, keeping the target around £14.20, as small adjustments to discount rate, revenue growth, profit margin and future P/E assumptions offset each other rather than driving a clear shift in valuation. What's in the News CVS Group completed a share buyback tranche, repurchasing 1,584,690 shares for £20 million, equal to 2.21% of the company.내러티브 업데이트 • Feb 04
CVSG: Completed Buyback And Steady Assumptions Will Support Balanced Near Term Returns
Analysts have nudged their price target on CVS Group slightly higher to reflect small updates to revenue growth and margin assumptions, while keeping fair value broadly unchanged in cash terms. What's in the News CVS Group completed a share buyback tranche covering 1,584,690 shares, representing 2.21% of the company, for a total of £20 million, under the programme announced on October 24, 2025 (Key Developments).내러티브 업데이트 • Jan 21
CVSG: Share Buyback And Steady Outlook Will Support Balanced Return Potential
Analysts have trimmed their price target on CVS Group to £14.20, citing slightly higher assumed revenue growth of 5.37% and a modestly stronger profit margin of 6.68%, offset by a marginally lower future P/E of 23.54x. What's in the News CVS Group plc has announced a share repurchase program of up to £20 million, with all repurchased ordinary shares to be cancelled as part of its capital allocation policy (Key Developments).분석 기사 • Jan 10
CVS Group (LON:CVSG) Is Doing The Right Things To Multiply Its Share Price
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...내러티브 업데이트 • Jan 07
CVSG: Higher Price Objective Will Be Supported By Share Repurchase Programme
Analysts have lifted their price target on CVS Group to £19.00 from £15.00, citing updated research that supports a higher valuation range for the shares. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a £19.00 price target as support for a higher valuation range, implying they view the current share price as not fully reflecting the company’s potential.내러티브 업데이트 • Dec 17
CVSG: Raised Share Price Outlook May Support Further Upside Potential
Analysts have raised their fair value estimate for CVS Group from approximately £12.50 to £14.20 per share, supported by higher Street price targets, including a recent increase to 1,900 GBp, even as they factor in a slightly higher discount rate and more moderate long term revenue growth and margins. Analyst Commentary While the latest price target increase to 1,900 GBp reflects growing confidence in the medium term trajectory, not all market observers are aligned with this more constructive outlook.내러티브 업데이트 • Dec 03
CVSG: Higher Price Objective Will Drive Returns Through Margin Expansion
Analysts have raised their price target for CVS Group to £19.00 from £15.00, reflecting improved expectations for profit margins and earnings sustainability, despite only minor adjustments to growth assumptions and valuation multiples. Analyst Commentary Analysts note that the higher price target reflects a more constructive view on the company’s execution and earnings profile, even as headline assumptions for top line expansion remain broadly unchanged.내러티브 업데이트 • Nov 19
CVSG: Outperform Rating Will Drive Shareholder Value With New Buyback Plan
Analysts have raised their price target for CVS Group shares from £15.00 to £19.00. They cite improved revenue growth and profit margin projections as factors supporting a more favorable outlook.분석 기사 • Nov 10
At UK£12.08, Is CVS Group plc (LON:CVSG) Worth Looking At Closely?
While CVS Group plc ( LON:CVSG ) might not have the largest market cap around , it received a lot of attention from a...내러티브 업데이트 • Nov 04
CVSG: Shares Will Gain From Buyback Programme and Dividend Increase
The analyst price target for CVS Group has been raised by £4.00 per share to £19.00, as analysts highlight ongoing confidence in the company's outlook following recent adjustments to growth and profitability forecasts. Analyst Commentary Following the recent price target revision, analysts have provided a range of perspectives on the company’s valuation, execution, and growth outlook.분석 기사 • Oct 24
Investors Appear Satisfied With CVS Group plc's (LON:CVSG) Prospects
With a price-to-earnings (or "P/E") ratio of 54.1x CVS Group plc ( LON:CVSG ) may be sending very bearish signals at...내러티브 업데이트 • Oct 21
Analysts Lift CVS Group Valuation Following Improved Growth and Dividend Announcement
Analysts have raised their price target for CVS Group from £15.44 to £16.43, citing improved revenue growth and profit margin expectations as key drivers for the upward revision. What's in the News The Board of CVS Group plc has recommended a final dividend payment of 8.5p per Ordinary share, an increase from 8.0p in 2024 (Key Developments).분석 기사 • Oct 08
Is There An Opportunity With CVS Group plc's (LON:CVSG) 30% Undervaluation?
Key Insights The projected fair value for CVS Group is UK£19.70 based on 2 Stage Free Cash Flow to Equity CVS Group's...분석 기사 • May 23
CVS Group plc's (LON:CVSG) P/E Is Still On The Mark Following 25% Share Price Bounce
CVS Group plc ( LON:CVSG ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...분석 기사 • Mar 14
CVS Group plc (LON:CVSG) Shares Could Be 44% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, CVS Group fair value estimate is UK£17.41 CVS Group is...
새로운 내러티브 • Feb 09
Australian Veterinary Expansion And Investments Will Create Future Opportunities
CVS Group's strategic expansions and acquisitions in Australia could drive future revenue growth and increased market share.분석 기사 • Jan 30
Market Participants Recognise CVS Group plc's (LON:CVSG) Earnings Pushing Shares 26% Higher
CVS Group plc ( LON:CVSG ) shareholders would be excited to see that the share price has had a great month, posting a...분석 기사 • Dec 04
CVS Group (LON:CVSG) Has A Somewhat Strained Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Oct 16
CVS Group plc's (LON:CVSG) Price In Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 27.2x CVS Group plc ( LON:CVSG ) may be sending very bearish signals at...분석 기사 • Sep 10
Should You Think About Buying CVS Group plc (LON:CVSG) Now?
CVS Group plc ( LON:CVSG ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...분석 기사 • Jun 05
CVS Group (LON:CVSG) Is Doing The Right Things To Multiply Its Share Price
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...분석 기사 • Mar 28
CVS Group (LON:CVSG) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Feb 29
CVS Group (LON:CVSG) Is Looking To Continue Growing Its Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...분석 기사 • Feb 09
Getting In Cheap On CVS Group plc (LON:CVSG) Is Unlikely
When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") below 15x, you may...분석 기사 • Dec 11
Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
While CVS Group plc ( LON:CVSG ) might not be the most widely known stock at the moment, it saw a decent share price...분석 기사 • Nov 23
Most Shareholders Will Probably Agree With CVS Group plc's (LON:CVSG) CEO Compensation
Key Insights CVS Group's Annual General Meeting to take place on 29th of November Salary of UK£430.0k is part of CEO...분석 기사 • Nov 15
Is CVS Group (LON:CVSG) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Oct 27
CVS Group plc's (LON:CVSG) Intrinsic Value Is Potentially 89% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, CVS Group fair value estimate is UK£26.21 Current share price...분석 기사 • Sep 23
Here's Why CVS Group (LON:CVSG) Has Caught The Eye Of Investors
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...분석 기사 • Sep 08
CVS Group's (LON:CVSG) Returns On Capital Are Heading Higher
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...분석 기사 • Jun 28
We Think CVS Group (LON:CVSG) Can Stay On Top Of Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...분석 기사 • May 25
Should You Investigate CVS Group plc (LON:CVSG) At UK£20.72?
CVS Group plc ( LON:CVSG ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...분석 기사 • May 12
A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Key Insights CVS Group's estimated fair value is UK£20.01 based on 2 Stage Free Cash Flow to Equity CVS Group's...분석 기사 • Apr 15
Should You Be Adding CVS Group (LON:CVSG) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...분석 기사 • Feb 01
A Look At The Fair Value Of CVS Group plc (LON:CVSG)
How far off is CVS Group plc ( LON:CVSG ) from its intrinsic value? Using the most recent financial data, we'll take a...분석 기사 • Jan 05
Here's Why We Think CVS Group (LON:CVSG) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...분석 기사 • Nov 30
Returns At CVS Group (LON:CVSG) Are On The Way Up
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...주주 수익률
| CVSG | GB Healthcare | GB 시장 | |
|---|---|---|---|
| 7D | 0% | 0.4% | 0.9% |
| 1Y | 0.3% | 3.6% | 16.3% |
수익률 대 산업: CVSG은 지난 1년 동안 3.6%의 수익을 기록한 UK Healthcare 산업보다 저조한 성과를 냈습니다.
수익률 대 시장: CVSG은 지난 1년 동안 16.3%를 기록한 UK 시장보다 저조한 성과를 냈습니다.
주가 변동성
| CVSG volatility | |
|---|---|
| CVSG Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 4.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
안정적인 주가: CVSG는 지난 3개월 동안 UK 시장에 비해 주가 변동성이 크지 않았습니다.
시간에 따른 변동성: CVSG의 주간 변동성(4%)은 지난 1년 동안 안정적이었습니다.
회사 소개
| 설립 | 직원 수 | CEO | 웹사이트 |
|---|---|---|---|
| 1999 | 9,000 | Richard William Fairman | www.cvsukltd.co.uk |
CVS Group plc는 자회사와 함께 영국과 호주에서 수의학, 온라인 약국 및 소매 사업을 영위하고 있습니다. 이 회사는 수의학 진료, 실험실 및 온라인 소매 사업 부문을 통해 운영됩니다. 이 회사는 동물 수의학 진료 및 보완적인 수의학 진단 사업에 관여하고 있습니다.
CVS Group plc 기초 지표 요약
| CVSG 기초 통계 | |
|---|---|
| 시가총액 | UK£887.02m |
| 순이익 (TTM) | UK£16.50m |
| 매출 (TTM) | UK£692.80m |
53.8x
주가수익비율(P/E)1.3x
주가매출비율(P/S)CVSG는 고평가되어 있습니까?
공정 가치 및 평가 분석 보기순이익 및 매출
| CVSG 손익계산서 (TTM) | |
|---|---|
| 매출 | UK£692.80m |
| 매출원가 | UK£393.20m |
| 총이익 | UK£299.60m |
| 기타 비용 | UK£283.10m |
| 순이익 | UK£16.50m |
최근 보고된 실적
Dec 31, 2025
다음 실적 발표일
Sep 24, 2026
| 주당순이익(EPS) | 0.24 |
| 총이익률 | 43.24% |
| 순이익률 | 2.38% |
| 부채/자본 비율 | 56.9% |
CVSG의 장기 실적은 어땠습니까?
과거 실적 및 비교 보기배당
0.7%
현재 배당 수익률37%
배당 성향기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/08/24 09:10 |
| 종가 | 2026/08/21 00:00 |
| 수익 | 2025/12/31 |
| 연간 수익 | 2025/06/30 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
CVS Group plc는 13명의 분석가가 다루고 있습니다. 이 중 9명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Sharanya Gajapathy | Barclays |
| James Bayliss | Berenberg |
| Allan Smylie | Davy |